Table 2. Quality of Surveillance PET and PET-CT studies.
| Study | Prospective study design? | Clear eligibility criteria? | Selection bias likely? | Index and reference tests adequately described? | Blinded outcome assessment? | Clear reporting with no discrepancies? | Overall grade |
|---|---|---|---|---|---|---|---|
| PET-CT | |||||||
|
| |||||||
| Lymphoma | |||||||
|
| |||||||
| Crocchiolo(22) | No | Yes | No | Yes | No | Yes | B |
| El-Galaly(23) | No | Yes | No | Yes | No | Yes | B |
|
| |||||||
| Lee(21) | No | Yes | Yes | No | No | Yes | C |
| Rhodes(24) | No | Yes | No | Yes | No | Yes | B |
|
| |||||||
| Head and Neck Cancer | |||||||
|
| |||||||
| Abgral(25) | Yes | Yes | No | Yes | Yes | Yes | A |
|
| |||||||
| PET | |||||||
|
| |||||||
| Lymphoma | |||||||
|
| |||||||
| Hosein(27) | No | Yes | Yes | Yes | No | Yes | C |
| Zinzani(26) | Yes | Yes | No | Yes | No | No | B |
|
| |||||||
| Head and Neck Cancer | |||||||
|
| |||||||
| Lowe(29) | Yes | Yes | Yes | Yes | Yes | No | B |
| Perie(30) | Yes | Yes | Yes | Yes | Yes | Yes | B |
| Salaun(31) | No | Yes | No | Yes | Yes | Yes | B |
|
| |||||||
| Colorectal Cancer | |||||||
|
| |||||||
| Selvaggi(28) | No | Yes | Yes | Yes | Yes | Yes | C |
| Sobhani(20) | Yes | Yes | No | Yes | Yes | No | B |